Polynovo Ltd (PNV) - Total Assets

Latest as of June 2025: AU$127.41 Million AUD ≈ $90.15 Million USD

Based on the latest financial reports, Polynovo Ltd (PNV) holds total assets worth AU$127.41 Million AUD (≈ $90.15 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Polynovo Ltd for net asset value and shareholders' equity analysis.

Polynovo Ltd - Total Assets Trend (1999–2025)

This chart illustrates how Polynovo Ltd's total assets have evolved over time, based on quarterly financial data.

Polynovo Ltd - Asset Composition Analysis

Current Asset Composition (June 2025)

Polynovo Ltd's total assets of AU$127.41 Million consist of 60.5% current assets and 39.5% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$6.91 Million	26.3%
Accounts Receivable	AU$24.39 Million	19.1%
Inventory	AU$14.49 Million	11.4%
Property, Plant & Equipment	AU$38.22 Million	30.0%
Intangible Assets	AU$661.00K	0.5%
Goodwill	AU$0.00	0.0%

Asset Composition Trend (1999–2025)

This chart illustrates how Polynovo Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Polynovo Ltd (PNV) total market value.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Polynovo Ltd's current assets represent 60.5% of total assets in 2025, a decrease from 78.7% in 1999.
Cash Position: Cash and equivalents constituted 26.3% of total assets in 2025, down from 76.7% in 1999.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 21.0% in 1999.
Asset Diversification: The largest asset category is property, plant & equipment at 30.0% of total assets.

Polynovo Ltd Competitors by Total Assets

Key competitors of Polynovo Ltd based on total assets are shown below.

Company	Country	Total Assets
Shenzhen New Industries Biomedical SHE:300832	China	CN¥9.58 Billion
Jafron Biomedical Co Ltd SHE:300529	China	CN¥5.54 Billion
Zhejiang Orient Gene Biotech Co Ltd SHG:688298	China	CN¥7.51 Billion
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	China	CN¥3.72 Billion
Guangdong Transtek Medical Electronics Co Ltd SHE:300562	China	CN¥1.42 Billion
Emvision Medical Devices Ltd AU:EMV	Australia	AU$15.57 Million
DRGEM Corporation KQ:263690	Korea	₩119.28 Billion
Diagnostic Medical Systems SA PA:ALDMS	France	€57.17 Million

Polynovo Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.77	3.41	2.03
Quick Ratio	2.25	3.03	1.91
Cash Ratio	0.25	1.04	0.00
Working Capital	AU$49.22 Million	AU$56.05 Million	AU$9.80 Million

Polynovo Ltd - Advanced Valuation Insights

This section examines the relationship between Polynovo Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	7.63
Latest Market Cap to Assets Ratio	3.84
Asset Growth Rate (YoY)	17.2%
Total Assets	AU$127.41 Million
Market Capitalization	$488.82 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Polynovo Ltd's assets at a significant premium (3.84x), suggesting investors see substantial growth potential or unique competitive advantages.

Rapid Asset Growth: Polynovo Ltd's assets grew by 17.2% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Polynovo Ltd (1999–2025)

The table below shows the annual total assets of Polynovo Ltd from 1999 to 2025.

Year	Total Assets	Change
2025-06-30	AU$127.41 Million ≈ $90.15 Million	+17.19%
2024-06-30	AU$108.72 Million ≈ $76.93 Million	+17.38%
2023-06-30	AU$92.62 Million ≈ $65.54 Million	+164.85%
2022-06-30	AU$34.97 Million ≈ $24.74 Million	-8.78%
2021-06-30	AU$38.34 Million ≈ $27.13 Million	+1.27%
2020-06-30	AU$37.86 Million ≈ $26.79 Million	+34.11%
2019-06-30	AU$28.23 Million ≈ $19.97 Million	-5.34%
2018-06-30	AU$29.82 Million ≈ $21.10 Million	+147.36%
2017-06-30	AU$12.06 Million ≈ $8.53 Million	-24.77%
2016-06-30	AU$16.02 Million ≈ $11.34 Million	+97.21%
2015-06-30	AU$8.13 Million ≈ $5.75 Million	-13.68%
2014-06-30	AU$9.41 Million ≈ $6.66 Million	+9.22%
2013-06-30	AU$8.62 Million ≈ $6.10 Million	-3.26%
2012-06-30	AU$8.91 Million ≈ $6.30 Million	-24.32%
2011-06-30	AU$11.77 Million ≈ $8.33 Million	-21.64%
2010-06-30	AU$15.02 Million ≈ $10.63 Million	-13.11%
2009-06-30	AU$17.29 Million ≈ $12.23 Million	+0.73%
2008-06-30	AU$17.16 Million ≈ $12.14 Million	-22.05%
2007-06-30	AU$22.02 Million ≈ $15.58 Million	-11.75%
2006-06-30	AU$24.95 Million ≈ $17.65 Million	+33.51%
2005-06-30	AU$18.69 Million ≈ $13.22 Million	+0.19%
2004-06-30	AU$18.65 Million ≈ $13.20 Million	+149.53%
2003-06-30	AU$7.47 Million ≈ $5.29 Million	-40.75%
2002-06-30	AU$12.61 Million ≈ $8.93 Million	+74.65%
2001-06-30	AU$7.22 Million ≈ $5.11 Million	-39.62%
2000-06-30	AU$11.96 Million ≈ $8.46 Million	+69.01%
1999-06-30	AU$7.08 Million ≈ $5.01 Million	--

About Polynovo Ltd

AU:PNV Australia Medical Devices

Market Cap

$488.82 Million

AU$690.84 Million AUD

Market Cap Rank

#12647 Global

#321 in Australia

Share Price

AU$1.00

Change (1 day)

+0.50%

52-Week Range

AU$0.88 - AU$1.67

All Time High

AU$4.01